Pharmacosmos A/s
Clinical trials sponsored by Pharmacosmos A/s, explained in plain language.
-
New hope to tame Chemo's harsh side effects and extend life for advanced lung cancer patients
Disease control Recruiting nowThis study is testing whether a drug called trilaciclib, given before chemotherapy, helps patients with advanced small cell lung cancer live longer. It also aims to see if it reduces severe side effects like low blood cell counts, which are common with chemotherapy. About 302 pat…
Phase: PHASE4 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug aims to clean dangerous iron from organs
Disease control Recruiting nowThis trial is testing a new drug called SP-420 to see if it can safely remove excess iron from the liver in adults with certain blood disorders. People with transfusion-dependent beta-thalassemia or low-risk myelodysplastic syndrome often need regular blood transfusions, which ca…
Phase: PHASE2 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC